Vaccination remains critical to public health and continued protection against serious consequences of COVID-19, including hospitalization and death, FDA vaccine chief Dr
A series of treatments is typically recommended, with maintenance sessions to help preserve results
According to the NICE Clinical Knowledge Summary (CKS) and the British National Formulary (BNF) , the standard treatment for B12 deficiency without neurological symptoms involves: Hydroxocobalamin 1 mg intramuscularly three times weekly for two weeks Followed by maintenance doses of 1 mg every three months For patients with neurological symptoms (such as paraesthesia, numbness, cognitive changes, or gait disturbances), more intensive treatment is required: Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement occurs Followed by 1 mg every two months for maintenance Pernicious anaemia , an autoimmune condition where the body cannot produce intrinsic factor, requires lifelong treatment
Additionally, individuals with active cancer are generally advised against NAD+ therapy due to theoretical risks of fueling cancer cell metabolism
It promotes growth, leading to swelling in joints and tissues
